Unity Biotechnology Inc (UBX) is up 10.19% in a Week, Should You Accumulate?

Unity Biotechnology Inc (UBX) is near the top in its industry group according to InvestorsObserver. UBX gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Unity Biotechnology Inc gets a 78 rank in the Biotechnology industry. Biotechnology is number 47 out of 148 industries.

UBX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on UBX!

See Full UBX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Unity Biotechnology Inc Stock Today?

Unity Biotechnology Inc (UBX) stock is up 5.42% while the S&P 500 is down -0.42% as of 10:37 AM on Tuesday, Aug 1. UBX is up $0.15 from the previous closing price of $2.77 on volume of 30,069 shares. Over the past year the S&P 500 is higher by 10.95% while UBX is down -55.08%. UBX lost -$5.02 per share the over the last 12 months. Click Here to get the full Stock Report for Unity Biotechnology Inc stock.